文献速递哮喘

成人起病哮喘肺功能加速下降的预测因素

Predictors of accelerated decline in lung function in adult-onset asthma.
PubMed 文献 · Eur Respir J · 2018-02-14

该研究对200例新诊断哮喘成人进行5年前瞻性随访,每年评估临床、功能及炎症指标,141例有可评估肺功能数据。新诊断成人哮喘中位支气管舒张后FEV1年下降17.5 mL;呼出气一氧化氮(FeNO)≥57 ppb且BMI≤23 kg·m-2者均出现FEV1加速下降。

要点

  • 新诊断成人哮喘中位支气管舒张后FEV1年变化为-17.5 mL。
  • FeNO≥57 ppb且BMI≤23 kg·m-2者均出现FEV1加速下降。
  • 鼻息肉、血及痰嗜酸性粒细胞、BMI、FeNO单变量与肺功能下降相关,仅后两者独立相关。

核心结论

  • 成人新发哮喘中高水平呼出气一氧化氮且低BMI者存在肺功能加速下降风险。

研究设计与样本

  • 前瞻性5年随访研究,纳入200例新诊断哮喘成人,每年评估临床、功能及炎症参数,采用线性混合效应模型识别预测因素,141例有可评估肺功能数据。

主要发现

  • 支气管舒张后FEV1中位(四分位距)年变化为-17.5(-54.2至+22.4)mL。
  • FEV1加速下降定义为下降幅度处于下四分位(>54.2 mL/年)。
  • 鼻息肉、血及痰嗜酸性粒细胞数、BMI、呼出气一氧化氮水平单变量与肺功能下降相关,仅后两者独立相关。
  • 以界值识别最高风险患者时,FeNO≥57 ppb且BMI≤23 kg·m-2者均出现FEV1加速下降。

关键数值与推荐

  • FEV1加速下降界值:>54.2 mL/年(下四分位)。
  • 高风险组合界值:FeNO≥57 ppb且BMI≤23 kg·m-2。

临床怎么用

  • 对成人新发哮喘应关注FeNO与BMI,高FeNO合并低BMI者需警惕肺功能加速下降并加强随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Little is known about the prognosis of adults with new-onset asthma. Cross-sectional studies suggest that these patients may exhibit accelerated decline in forced expiratory volume in 1 s (FEV1). However, risk factors for accelerated decline in lung function have not yet been identified.We aimed to identify these risk factors in a prospective 5-year follow-up study in 200 adults with newly diagnosed asthma. In the current study, clinical, functional and inflammatory parameters were assessed annually for 5 years. Linear mixed-effects models were used to identify predictors.Evaluable lung function sets of 141 patients were available. Median (interquartile range) change in post-bronchodilator FEV1 was -17.5 (-54.2 to +22.4) mL per year. Accelerated decline in FEV1 was defined by the lower quartile of decline (>54.2 mL per year). Nasal polyps, number of blood and sputum eosinophils, body mass index, and level of exhaled nitric oxide were univariably associated with decline in lung function. Only the latter two were independently associated. Using cut-off values to identify patients at highest risk showed accelerated decline in FEV1 in all patients with combined exhaled nitric oxide fraction (FeNO) ≥57 ppb and body mass index (BMI) ≤23 kg·m-2We conclude that adults with new-onset asthma with both high levels of exhaled nitric oxide and low BMI are at risk of accelerated decline in lung function.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Coumou H, Westerhof GA, de Nijs SB, et al. Predictors of accelerated decline in lung function in adult-onset asthma. Eur Respir J. 2018. PMID: 29444915. doi:10.1183/13993003.01785-2017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。